Akebia Therapeutics Inc (NASDAQ: AKBA) is a biopharmaceutical company focused on the development and commercialization of therapeutics for kidney disease. The filing excerpts provided do not contain sufficient detail to describe the revenue model, product portfolio, competitive position, geographic footprint, or financial metrics with the specificity required. Based solely on the available filing content, no further factual claims about Akebia's business operations, revenue streams, customer base, or market position can be supported.

Source: SEC 10-K, filed 2026-02-26

Industry: Pharmaceutical Preparations Peers: AquaBounty Technologies Inc Atreca, Inc. BioVie Inc Unity Biotechnology, Inc. Disc Medicine Inc GT Biopharma Inc EOM Pharmaceutical Holdings, Inc. Palatin Technologies Inc Solid Biosciences Inc